NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced today that it has priced a €500 million ($527.9 million) offering of senior notes.
The 1.450 percent senior notes are due 2027 at an issue price of 98.824 percent of the principal amount. Thermo Fisher said it plans to use approximately $508 million of the net proceeds to redeem all of the outstanding $500 million aggregate principal amount of its 1.850 percent senior notes that mature on Jan. 15, 2018. The company also plans to pay accrued interest, fees, and expenses associated with the redemption. Any remaining net proceeds will be used for general corporate purposes.
The issuance of the notes is expected to close around March 16. The joint book-running managers for the offering are Credit Suisse Securities and HSBC Bank.